Shree Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 48.77%
- Profit Growth 5.73%
- Ebitda 268.67%
- Net Worth 75.12%
- Total Assets 61.21%
About Shree Life Sciences
Shree Life Sciences Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 March 2008 and has a history of 16 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rinki Shahi and Arvind Shahi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2008PTC179638
-
Company No.
179638
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Mar 2008
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Shree Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rinki Shahi
|
Director | 26-Nov-2008 | Current |
|
Arvind Shahi
|
Director | 03-Mar-2008 | Current |
Financial Performance of Shree Life Sciences.
Shree Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 48.77% increase. The company also saw a slight improvement in profitability, with a 5.73% increase in profit. The company's net worth Soared by an impressive increase of 75.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Life Sciences?
In 2020, Shree Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Stenora Pharma Private LimitedRinki Shahi and Arvind Shahi are mutual person
-
Anaveom Healthcare Private Limited
Arvind Shahi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Life Sciences?
Shree Life Sciences has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
